ARAY Stock Analysis: Buy, Sell, or Hold?
ARAY - Accuray Incorporated
$0.28
0.01 (3.67%)
▲
5d:
+23.53%
30d:
+9.04%
90d:
-40.44%
BUY
HIGH Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 12, 2026
8d
Get Alerted When ARAY Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ARAY shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: ARAY shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: ARAY is currently trading at $0.28, which is considered fair relative to its 30-day fair value range of $0.24 to $0.29. From a valuation perspective, the stock is trading at a discount (Forward PE: -0.9) compared to its historical average (39.3). At these levels, the market is pricing in 0% annual earnings growth.
Technical Outlook: Technically, ARAY is in a strong downtrend. Immediate support is located at $0.22, while resistance sits at $0.30. The stock is showing strong short-term momentum, up 3.7% recently.
Market Sentiment: ARAY has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $0.35 (+30.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ARAY is in a strong downtrend. Immediate support is located at $0.22, while resistance sits at $0.30. The stock is showing strong short-term momentum, up 3.7% recently.
Market Sentiment: ARAY has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $0.35 (+30.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$0.24 -
$0.29
Company Quality Score
44/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
88.1%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.7%)
- BULLISH: Trading 30.5% below Wall St target ($0.35)
Trading Range Analysis
30-Day Trading Range
$0.24 -
$0.29
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$0.22
Resistance Level
$0.30
Current Trend
Strong Downtrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.89
Wall Street Target
$0.35
(+30.5%)
Revenue Growth (YoY)
-7.4%
Earnings Growth (YoY)
-96.2%
Profit Margin
-10.8%
PE vs Historical
-0.9 vs 39.3
CHEAP
Share & Embed Analysis
Last updated: August 03, 2026 12:32 PM ET
Data refreshes hourly during market hours. Next update: 1:32 PM
Data refreshes hourly during market hours. Next update: 1:32 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ARAY showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$64 | 55 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$93 | 49 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$384 | 51 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$118 | 52 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 57 HOLD |
Advanced ARAY Option Strategies
Professional options setups generated by AI based on today's ARAY price and gamma walls.
